{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:45:29Z","timestamp":1778795129369,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013726","name":"Abraham J. and Phyllis Katz Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL129511"],"award-info":[{"award-number":["R01HL129511"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL150887"],"award-info":[{"award-number":["R01HL150887"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI16C2211"],"award-info":[{"award-number":["HI16C2211"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["No. 2020R1A2C3003784"],"award-info":[{"award-number":["No. 2020R1A2C3003784"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Preeclampsia (PE) is a prevalent pregnancy disorder that leads to high maternal and fetal morbidity and mortality. While defective vascular development and angiogenesis in placenta are known as crucial pathological findings, its pathophysiological mechanism remains elusive. To better understand the effects of PE on angio-vasculogenesis and inflammatory networks in the fetus and to identify their biological signatures, we investigated the quantitative and functional characteristics of cord blood-derived mononuclear cells (CB-MNCs) and CD31-positive MNCs. Flow cytometry analysis demonstrated that the CB-MNCs from the severe PE group had significantly decreased number of cells expressing CD3, CD11b, CD14, CD19, KDR, and CD31 compared with the normal group. Quantitative real time PCR (qRT-PCR) shows down-regulation of the major angiogenic factor <jats:italic>VEGFA<\/jats:italic> in MNCs and CD31<jats:sup>+<\/jats:sup> MNCs in severe PE<jats:italic>.<\/jats:italic> The major inflammatory cytokines IL1 was highly upregulated in CD31<jats:sup>+<\/jats:sup> CB-MNCs in the severe PE patients. Mild PE patients, however, did not display any significant difference in expression of all measured angiogenic genes and most inflammatory genes. These findings show distinct angiogenic and inflammatory signatures from severe PE, and they may play a significant role in the pathogenesis of vascular defects in placenta of severe PE.<\/jats:p>","DOI":"10.1038\/s41598-021-83146-8","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T11:03:58Z","timestamp":1613041438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reduced angiovasculogenic and increased inflammatory profiles of cord blood cells in severe but not mild preeclampsia"],"prefix":"10.1038","volume":"11","author":[{"given":"Seonggeon","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Doug","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangsung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina L.","family":"Badell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Sidell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-sup","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"83146_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","volume":"357","author":"JM Roberts","year":"2001","unstructured":"Roberts, J. M. & Cooper, D. W. Pathogenesis and genetics of pre-eclampsia. Lancet 357, 53\u201356 (2001).","journal-title":"Lancet"},{"key":"83146_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley, L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33, 130\u2013137. https:\/\/doi.org\/10.1053\/j.semperi.2009.02.010 (2009).","journal-title":"Semin. Perinatol."},{"key":"83146_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BW Mol","year":"2016","unstructured":"Mol, B. W. et al. Pre-eclampsia. Lancet 387, 999\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(15)00070-7 (2016).","journal-title":"Lancet"},{"key":"83146_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","volume":"51","author":"B Huppertz","year":"2008","unstructured":"Huppertz, B. Placental origins of preeclampsia. Hypertension 51, 970\u2013975. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.107607 (2008).","journal-title":"Hypertension"},{"key":"83146_CR5","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1067\/mob.2002.127305","volume":"187","author":"JJ Brosens","year":"2002","unstructured":"Brosens, J. J., Pijnenborg, R. & Brosens, I. A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. Am. J. Obstet. Gynecol. 187, 1416\u20131423. https:\/\/doi.org\/10.1067\/mob.2002.127305 (2002).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"83146_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/AOG.0000000000000696","volume":"125","author":"QE Harmon","year":"2015","unstructured":"Harmon, Q. E. et al. Risk of fetal death with preeclampsia. Obstet. Gynecol. 125, 628\u2013635. https:\/\/doi.org\/10.1097\/AOG.0000000000000696 (2015).","journal-title":"Obstet. Gynecol."},{"key":"83146_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2393-14-63","volume":"14","author":"J Unterscheider","year":"2014","unstructured":"Unterscheider, J. et al. Fetal growth restriction and the risk of perinatal mortality\u2013case studies from the multicentre PORTO study. BMC Pregnancy Childbirth 14, 63. https:\/\/doi.org\/10.1186\/1471-2393-14-63 (2014).","journal-title":"BMC Pregnancy Childbirth"},{"key":"83146_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","volume":"2","author":"DJ Barker","year":"1989","unstructured":"Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight in infancy and death from ischaemic heart disease. Lancet 2, 577\u2013580 (1989).","journal-title":"Lancet"},{"key":"83146_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1741-4520.2012.00359.x","volume":"52","author":"A Taki","year":"2012","unstructured":"Taki, A. et al. Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis\/funisitis. Congenit Anom (Kyoto) 52, 97\u2013103. https:\/\/doi.org\/10.1111\/j.1741-4520.2012.00359.x (2012).","journal-title":"Congenit Anom (Kyoto)"},{"key":"83146_CR10","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1172\/JCI76864","volume":"124","author":"X Fan","year":"2014","unstructured":"Fan, X. et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J. Clin. Invest. 124, 4941\u20134952. https:\/\/doi.org\/10.1172\/JCI76864 (2014).","journal-title":"J. Clin. Invest."},{"key":"83146_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrneph.2014.102","volume":"10","author":"T Chaiworapongsa","year":"2014","unstructured":"Chaiworapongsa, T., Chaemsaithong, P., Yeo, L. & Romero, R. Pre-eclampsia part 1: Current understanding of its pathophysiology. Nat. Rev. Nephrol. 10, 466\u2013480. https:\/\/doi.org\/10.1038\/nrneph.2014.102 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"83146_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/aje\/kwq373","volume":"173","author":"BO Asvold","year":"2011","unstructured":"Asvold, B. O. et al. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am. J. Epidemiol. 173, 630\u2013639. https:\/\/doi.org\/10.1093\/aje\/kwq373 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"83146_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642. https:\/\/doi.org\/10.1038\/nm1429 (2006).","journal-title":"Nat. Med."},{"key":"83146_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/1933719110366164","volume":"17","author":"P Luppi","year":"2010","unstructured":"Luppi, P. et al. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod. Sci. 17, 643\u2013652. https:\/\/doi.org\/10.1177\/1933719110366164 (2010).","journal-title":"Reprod. Sci."},{"key":"83146_CR15","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1210\/jc.2005-0532","volume":"90","author":"J Sugawara","year":"2005","unstructured":"Sugawara, J. et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J. Clin. Endocrinol. Metab. 90, 5329\u20135332. https:\/\/doi.org\/10.1210\/jc.2005-0532 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"83146_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1447-0756.2007.00555.x","volume":"33","author":"L Xia","year":"2007","unstructured":"Xia, L. et al. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J. Obstet. Gynaecol. Res. 33, 465\u2013474. https:\/\/doi.org\/10.1111\/j.1447-0756.2007.00555.x (2007).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"83146_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1067\/mob.2001.117343","volume":"185","author":"DV Surbek","year":"2001","unstructured":"Surbek, D. V. et al. Effect of preeclampsia on umbilical cord blood hematopoietic progenitor-stem cells. Am. J. Obstet. Gynecol. 185, 725\u2013729. https:\/\/doi.org\/10.1067\/mob.2001.117343 (2001).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"83146_CR18","doi-asserted-by":"crossref","unstructured":"Hiett, A. et al. Comparison of Hematopoietic Progenitor Cells in Human Umbilical Cord Blood Collected from Neonatal Infants who Are Small and Appropriate for Gestational Age. Vol. 35 (1995).","DOI":"10.1046\/j.1537-2995.1995.35795357882.x"},{"key":"83146_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1203\/00006450-199803000-00007","volume":"43","author":"T Stallmach","year":"1998","unstructured":"Stallmach, T. et al. Fetuses from preeclamptic mothers show reduced hepatic erythropoiesis. Pediatr. Res. 43, 349. https:\/\/doi.org\/10.1203\/00006450-199803000-00007 (1998).","journal-title":"Pediatr. Res."},{"key":"83146_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/HYPERTENSIONAHA.113.03058","volume":"64","author":"R Mu\u00f1oz-Hernandez","year":"2014","unstructured":"Mu\u00f1oz-Hernandez, R. et al. Decreased level of cord blood circulating endothelial colony-forming cells in Preeclampsia. Hypertension 64, 165\u2013171. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.03058 (2014).","journal-title":"Hypertension"},{"key":"83146_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jacc.2010.01.070","volume":"56","author":"SW Kim","year":"2010","unstructured":"Kim, S. W. et al. Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol 56, 593\u2013607. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.070 (2010).","journal-title":"J Am Coll Cardiol"},{"key":"83146_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/CIRCRESAHA.110.218396","volume":"107","author":"H Kim","year":"2010","unstructured":"Kim, H. et al. CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: Novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res 107, 602\u2013614. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.218396 (2010).","journal-title":"Circ Res"},{"key":"83146_CR23","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1111\/jcmm.12370","volume":"18","author":"MH Kim","year":"2014","unstructured":"Kim, M. H., Guo, L., Kim, H. S. & Kim, S. W. Characteristics of circulating CD31(+) cells from patients with coronary artery disease. J Cell Mol Med 18, 2321\u20132330. https:\/\/doi.org\/10.1111\/jcmm.12370 (2014).","journal-title":"J Cell Mol Med"},{"key":"83146_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"American College of Obstetricians and Gynecologists. \"Hypertension in pregnancy","year":"2013","unstructured":"American College of Obstetricians and Gynecologists. \"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 122, 1122\u20131131. https:\/\/doi.org\/10.1097\/01.AOG.0000437382.03963.88 (2013).","journal-title":"Obstet. Gynecol."},{"key":"83146_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.tibtech.2017.06.008","volume":"35","author":"AA Abdeen","year":"2017","unstructured":"Abdeen, A. A. & Saha, K. Manufacturing cell therapies using engineered biomaterials. Trends Biotechnol. 35, 971\u2013982. https:\/\/doi.org\/10.1016\/j.tibtech.2017.06.008 (2017).","journal-title":"Trends Biotechnol."},{"key":"83146_CR26","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","volume":"107","author":"J Rehman","year":"2003","unstructured":"Rehman, J., Li, J., Orschell, C. M. & March, K. L. Peripheral blood \u201cendothelial progenitor cells\u201d are derived from monocyte\/macrophages and secrete angiogenic growth factors. Circulation 107, 1164\u20131169 (2003).","journal-title":"Circulation"},{"key":"83146_CR27","first-page":"453","volume":"58","author":"D Peleg","year":"1998","unstructured":"Peleg, D., Kennedy, C. M. & Hunter, S. K. Intrauterine growth restriction: Identification and management. Am. Fam. Phys. 58, 453\u2013460 (1998).","journal-title":"Am. Fam. Phys."},{"key":"83146_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5115\/acb.19.158","volume":"53","author":"S Chillakuru","year":"2020","unstructured":"Chillakuru, S., Velichety, S. D. & Rajagopalan, V. Human umbilical cord and its vessels: A histomorphometric study in difference severity of hypertensive disorders of pregnancy. Anat. Cell Biol. 53, 68\u201375. https:\/\/doi.org\/10.5115\/acb.19.158 (2020).","journal-title":"Anat. Cell Biol."},{"key":"83146_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.placenta.2016.11.014","volume":"49","author":"EM Herzog","year":"2017","unstructured":"Herzog, E. M. et al. Impact of early- and late-onset preeclampsia on features of placental and newborn vascular health. Placenta 49, 72\u201379. https:\/\/doi.org\/10.1016\/j.placenta.2016.11.014 (2017).","journal-title":"Placenta"},{"key":"83146_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/uog.7450","volume":"34","author":"F Crispi","year":"2009","unstructured":"Crispi, F. et al. Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction?. Ultrasound Obstet. Gynecol. 34, 660\u2013665. https:\/\/doi.org\/10.1002\/uog.7450 (2009).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"83146_CR31","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1084\/jem.178.6.2077","volume":"178","author":"A Kaipainen","year":"1993","unstructured":"Kaipainen, A. et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178, 2077\u20132088. https:\/\/doi.org\/10.1084\/jem.178.6.2077 (1993).","journal-title":"J. Exp. Med."},{"key":"83146_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jash.2011.11.003","volume":"6","author":"D Burger","year":"2012","unstructured":"Burger, D. & Touyz, R. M. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc. Hypertens. 6, 85\u201399. https:\/\/doi.org\/10.1016\/j.jash.2011.11.003 (2012).","journal-title":"J Am Soc. Hypertens."},{"key":"83146_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1160\/TH04-09-0578","volume":"93","author":"AD Blann","year":"2005","unstructured":"Blann, A. D. et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb. Haemost. 93, 228\u2013235. https:\/\/doi.org\/10.1160\/TH04-09-0578 (2005).","journal-title":"Thromb. Haemost."},{"key":"83146_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tcm.2015.01.013","volume":"25","author":"DE Schmidt","year":"2015","unstructured":"Schmidt, D. E., Manca, M. & Hoefer, I. E. Circulating endothelial cells in coronary artery disease and acute coronary syndrome. Trends Cardiovasc. Med. 25, 578\u2013587. https:\/\/doi.org\/10.1016\/j.tcm.2015.01.013 (2015).","journal-title":"Trends Cardiovasc. Med."},{"key":"83146_CR35","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jacc.2006.02.078","volume":"48","author":"CJ Boos","year":"2006","unstructured":"Boos, C. J., Lip, G. Y. & Blann, A. D. Circulating endothelial cells in cardiovascular disease. J. Am. Coll. Cardiol. 48, 1538\u20131547. https:\/\/doi.org\/10.1016\/j.jacc.2006.02.078 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"83146_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","volume":"6","author":"L Yang","year":"2004","unstructured":"Yang, L. et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6, 409\u2013421. https:\/\/doi.org\/10.1016\/j.ccr.2004.08.031 (2004).","journal-title":"Cancer Cell"},{"key":"83146_CR37","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.107.694778","volume":"116","author":"J Hur","year":"2007","unstructured":"Hur, J. et al. Identification of a novel role of T cells in postnatal vasculogenesis: Characterization of endothelial progenitor cell colonies. Circulation 116, 1671\u20131682. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.694778 (2007).","journal-title":"Circulation"},{"key":"83146_CR38","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.jacc.2014.06.1204","volume":"64","author":"SW Kim","year":"2014","unstructured":"Kim, S. W., Houge, M., Brown, M., Davis, M. E. & Yoon, Y. S. Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects. J. Am. Coll. Cardiol 64, 1681\u20131694. https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1204 (2014).","journal-title":"J. Am. Coll. Cardiol"},{"key":"83146_CR39","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1161\/01.CIR.0000096483.29777.50","volume":"108","author":"C Urbich","year":"2003","unstructured":"Urbich, C. et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108, 2511 (2003).","journal-title":"Circulation"},{"key":"83146_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","volume":"11","author":"AM Borzychowski","year":"2006","unstructured":"Borzychowski, A. M., Sargent, I. L. & Redman, C. W. Inflammation and pre-eclampsia. Semin. Fetal Neonatal. Med. 11, 309\u2013316. https:\/\/doi.org\/10.1016\/j.siny.2006.04.001 (2006).","journal-title":"Semin. Fetal Neonatal. Med."},{"key":"83146_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon, A. C. et al. The role of inflammation in the pathology of preeclampsia. Clin. Sci. (Lond.) 130, 409\u2013419. https:\/\/doi.org\/10.1042\/CS20150702 (2016).","journal-title":"Clin. Sci. (Lond.)"},{"key":"83146_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5830\/cvja-2017-039","volume":"29","author":"I Bhorat","year":"2018","unstructured":"Bhorat, I. Pre-eclampsia and the foetus: A cardiovascular perspective. Cardiovasc. J. Afr. 29, 387\u2013393. https:\/\/doi.org\/10.5830\/cvja-2017-039 (2018).","journal-title":"Cardiovasc. J. Afr."},{"key":"83146_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/uog.5402","volume":"32","author":"W Plasencia","year":"2008","unstructured":"Plasencia, W., Maiz, N., Poon, L., Yu, C. & Nicolaides, K. H. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet. Gynecol. 32, 138\u2013146. https:\/\/doi.org\/10.1002\/uog.5402 (2008).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"83146_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-2008-1075034","volume":"25","author":"LM Gupta","year":"2008","unstructured":"Gupta, L. M., Gaston, L. & Chauhan, S. P. Detection of fetal growth restriction with preterm severe preeclampsia: Experience at two tertiary centers. Am. J. Perinatol. 25, 247\u2013249. https:\/\/doi.org\/10.1055\/s-2008-1075034 (2008).","journal-title":"Am. J. Perinatol."},{"key":"83146_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1172\/JCI22326","volume":"115","author":"YS Yoon","year":"2005","unstructured":"Yoon, Y. S. et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115, 326\u2013338. https:\/\/doi.org\/10.1172\/JCI22326 (2005).","journal-title":"J. Clin. Invest."},{"key":"83146_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309833","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. Direct reprogramming of human dermal fibroblasts into endothelial cells using ER71\/ETV2. Circ. Res. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309833 (2016).","journal-title":"Circ. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83146-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:30:58Z","timestamp":1670038258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83146-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83146"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83146-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3630"}}